{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:13:28Z","timestamp":1791976408123,"version":"4.4.0"},"reference-count":56,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1111\/jcpt.12768","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T01:22:27Z","timestamp":1539307347000},"page":"129-133","source":"Crossref","is-referenced-by-count":32,"title":["Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?"],"prefix":"10.1155","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8280-6467","authenticated-orcid":false,"given":"Rashmi R.","family":"Shah","sequence":"first","affiliation":[{"name":"Pharmaceutical Consultant; Buckinghamshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"10.1111\/jcpt.12768-BIB0001|jcpt12768-cit-0001","first-page":"8","article-title":"Britons die after taking Spanish painkiller","author":"Ungoed-Thomas","journal-title":"The Sunday Times (London)"},{"key":"10.1111\/jcpt.12768-BIB0002|jcpt12768-cit-0002","first-page":"176-179","article-title":"[Agranulocytosis from metamizole: a potential problem for the British population]","volume":"209","author":"M\u00e9rida Rodrigo","year":"2009","journal-title":"Rev Clin Esp"},{"key":"10.1111\/jcpt.12768-BIB0003|jcpt12768-cit-0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","article-title":"Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)","volume":"58","author":"Hedenmalm","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0004|jcpt12768-cit-0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","article-title":"Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports","volume":"71","author":"Blaser","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0005|jcpt12768-cit-0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","article-title":"Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012","volume":"71","author":"Stammschulte","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0006|jcpt12768-cit-0006","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","article-title":"Agranulocytosis associated with dipyrone (metamizol)","volume":"60","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0007|jcpt12768-cit-0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2015.04.003","article-title":"Prescription opioid abuse: Problems and responses","volume":"80","author":"Compton","year":"2015","journal-title":"Prev Med"},{"key":"10.1111\/jcpt.12768-BIB0008|jcpt12768-cit-0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5055\/jom.2017.0417","article-title":"Opioids with abuse-deterrent properties: a regulatory and technological overview","volume":"13","author":"Haddox","year":"2017","journal-title":"J Opioid Manag"},{"key":"10.1111\/jcpt.12768-BIB0009|jcpt12768-cit-0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s002280100341","article-title":"Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators","volume":"57","author":"Levy","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0010|jcpt12768-cit-0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2165\/00003088-199528030-00004","article-title":"Clinical pharmacokinetics of dipyrone and its metabolites","volume":"28","author":"Levy","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12768-BIB0011|jcpt12768-cit-0011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s002280050511","article-title":"Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone","volume":"54","author":"Cohen","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0012|jcpt12768-cit-0012","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00549594","article-title":"Plasma kinetics of dipyrone metabolites in rapid and slow acetylators","volume":"27","author":"Levy","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0013|jcpt12768-cit-0013","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5414\/CPP48791","article-title":"Population pharmacokinetic analysis of the active product of dipyrone","volume":"48","author":"Levy","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12768-BIB0014|jcpt12768-cit-0014","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/bmj.1.4457.876","article-title":"Agranulocytosis due to novaldin","volume":"1","author":"Kneedler","year":"1946","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12768-BIB0015|jcpt12768-cit-0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jcpt.12422","article-title":"Safety of metamizole: a systematic review of the literature","volume":"41","author":"Andrade","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12768-BIB0016|jcpt12768-cit-0016","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/030006057900700617","article-title":"The incidence of dipyrone-induced agranulocytosis in Greece during 1975","volume":"7","author":"Varonos","year":"1979","journal-title":"J Int Med Res"},{"key":"10.1111\/jcpt.12768-BIB0017|jcpt12768-cit-0017","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/147323000203000504","article-title":"The incidence of metamizole sodium-induced agranulocytosis in Poland","volume":"30","author":"Maj","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1111\/jcpt.12768-BIB0018|jcpt12768-cit-0018","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/147323001003800419","article-title":"Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland","volume":"38","author":"Basak","year":"2010","journal-title":"J Int Med Res"},{"key":"10.1111\/jcpt.12768-BIB0019|jcpt12768-cit-0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","article-title":"Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study","volume":"71","author":"Huber","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0020|jcpt12768-cit-0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00228-008-0513-7","article-title":"Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study: a multicenter study","volume":"64","author":"Hamerschlak","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0021|jcpt12768-cit-0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/03009742.1998.11720787","article-title":"Nonsteroidal anti-inflammatory drugs during pregnancy","volume":"107","author":"Ostensen","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1111\/jcpt.12768-BIB0022|jcpt12768-cit-0022","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00228-017-2385-1","article-title":"Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study","volume":"74","author":"Dathe","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12768-BIB0023|jcpt12768-cit-0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2004.07.004","article-title":"Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study","volume":"119","author":"Bar-Oz","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1111\/jcpt.12768-BIB0024|jcpt12768-cit-0024","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/pds.4277","article-title":"Metamizole use during first trimester - a prospective observational cohort study on pregnancy outcome","volume":"26","author":"Dathe","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12768-BIB0025|jcpt12768-cit-0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/papr.12467","article-title":"Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs","volume":"17","author":"Konijnenbelt-Peters","year":"2017","journal-title":"Pain Pract"},{"key":"10.1111\/jcpt.12768-BIB0026|jcpt12768-cit-0026","doi-asserted-by":"crossref","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","article-title":"Metamizole-associated adverse events: a systematic review and meta-analysis","volume":"10","author":"K\u00f6tter","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jcpt.12768-BIB0027|jcpt12768-cit-0027","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/ejp.1194","article-title":"Dipyrone is the preferred nonopioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German-speaking countries","volume":"22","author":"Reist","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1111\/jcpt.12768-BIB0028|jcpt12768-cit-0028","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/10601333.2015.1064131","article-title":"Interethnic differences in drug response: Implications for drug development and complying with drug regulation","volume":"32","author":"Shah","year":"2015","journal-title":"Clin Res Reg Affairs"},{"key":"10.1111\/jcpt.12768-BIB0029|jcpt12768-cit-0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-146-1-200701020-00010","article-title":"BiDil for heart failure in black patients: the U.S. Food and Drug Administration perspective","volume":"146","author":"Temple","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12768-BIB0030|jcpt12768-cit-0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bmj.1.4919.950","article-title":"Fatal agranulocytosis during treatment with chlorpromazine","volume":"1","author":"Tasker","year":"1955","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12768-BIB0031|jcpt12768-cit-0031","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bmj.1.4975.1087-a","article-title":"Agranulocytosis and severe leucopenia after chlorpromazine hydrochloride","volume":"1","author":"Adams","year":"1956","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12768-BIB0032|jcpt12768-cit-0032","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1056\/NEJM195610252551703","article-title":"Agranulocytosis associated with chlorpromazine therapy; report of a case and review of the literature","volume":"255","author":"Schick","year":"1956","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12768-BIB0033|jcpt12768-cit-0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00000441-196101000-00006","article-title":"Granulocytopenia due to chlorpromazine: a report of 11 cases","volume":"241","author":"Carfagno","year":"1961","journal-title":"Am J Med Sci"},{"key":"10.1111\/jcpt.12768-BIB0034|jcpt12768-cit-0034","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bmj.2.5052.1048","article-title":"Chlorpromazine jaundice","volume":"2","author":"Lambo","year":"1957","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12768-BIB0035|jcpt12768-cit-0035","doi-asserted-by":"crossref","first-page":"3186328","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions","volume":"2017","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1111\/jcpt.12768-BIB0036|jcpt12768-cit-0036","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000232788","article-title":"Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies","volume":"65","author":"Hodinka","year":"1981","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1111\/jcpt.12768-BIB0037|jcpt12768-cit-0037","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13104-015-1219-4","article-title":"Genetic determinants of cocaine-associated agranulocytosis","volume":"8","author":"Buxton","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1111\/jcpt.12768-BIB0038|jcpt12768-cit-0038","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V86.3.1177.1177","article-title":"HLA associations in clozapine-induced agranulocytosis","volume":"86","author":"Yunis","year":"1995","journal-title":"Blood"},{"key":"10.1111\/jcpt.12768-BIB0039|jcpt12768-cit-0039","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.biopsych.2015.12.006","article-title":"Pharmacogenomic study of clozapine-induced agranulocytosis\/granulocytopenia in a Japanese population","volume":"80","author":"Saito","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1111\/jcpt.12768-BIB0040|jcpt12768-cit-0040","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/ncomms8633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","author":"Chen","year":"2015","journal-title":"Nat Commun"},{"key":"10.1111\/jcpt.12768-BIB0041|jcpt12768-cit-0041","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cpt.309","article-title":"HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis","volume":"99","author":"Cheung","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12768-BIB0042|jcpt12768-cit-0042","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1038\/s41598-017-12350-2","article-title":"Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"10.1111\/jcpt.12768-BIB0043|jcpt12768-cit-0043","doi-asserted-by":"crossref","first-page":"7965346","DOI":"10.1155\/2018\/7965346","article-title":"Association of HLA-B\u221738:02 with antithyroid drug-induced agranulocytosis in Kinh Vietnamese patients","volume":"2018","author":"Thao","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1111\/jcpt.12768-BIB0044|jcpt12768-cit-0044","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/cpt.805","article-title":"Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus","volume":"103","author":"Wadelius","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12768-BIB0045|jcpt12768-cit-0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","article-title":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","volume":"4","author":"Hallberg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1111\/jcpt.12768-BIB0046|jcpt12768-cit-0046","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","article-title":"Drug-induced immune neutropenia\/agranulocytosis","volume":"30","author":"Curtis","year":"2014","journal-title":"Immunohematology"},{"key":"10.1111\/jcpt.12768-BIB0047|jcpt12768-cit-0047","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jcpt.12768-BIB0048|jcpt12768-cit-0048","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.2830310314","article-title":"Agranulocytosis associated with \"Mexican aspirin\" (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors","volume":"31","author":"Hargis","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1111\/jcpt.12768-BIB0049|jcpt12768-cit-0049","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1537-2995.1999.39050527.x","article-title":"Demonstration of drug-dependent antibodies in two patients with neutropenia and successful treatment with granulocyte-colony-stimulating factor","volume":"39","author":"Meyer","year":"1999","journal-title":"Transfusion"},{"key":"10.1111\/jcpt.12768-BIB0050|jcpt12768-cit-0050","first-page":"81","article-title":"Chronic use of metamizole: not so safe after all?","volume":"75","author":"Vuik","year":"2017","journal-title":"Neth J Med"},{"key":"10.1111\/jcpt.12768-BIB0051|jcpt12768-cit-0051","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008571-199602000-00005","article-title":"Genetic factors and risk of agranulocytosis from metamizol","volume":"6","author":"Vlahov","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1111\/jcpt.12768-BIB0052|jcpt12768-cit-0052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.hdy.6800695","article-title":"Human migration: reappraising the Viking image","volume":"95","author":"McEvoy","year":"2005","journal-title":"Heredity (Edinb)"},{"key":"10.1111\/jcpt.12768-BIB0053|jcpt12768-cit-0053","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.ejhg.5201709","article-title":"The scale and nature of Viking settlement in Ireland from Y-chromosome admixture analysis","volume":"14","author":"McEvoy","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/jcpt.12768-BIB0054|jcpt12768-cit-0054","doi-asserted-by":"crossref","first-page":"20130384","DOI":"10.1098\/rstb.2013.0384","article-title":"Mitochondrial DNA variation in the Viking age population of Norway","volume":"370","author":"Krzewi\u0144ska","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1111\/jcpt.12768-BIB0055|jcpt12768-cit-0055","doi-asserted-by":"crossref","first-page":"17199","DOI":"10.1038\/s41598-017-17124-4","article-title":"The Irish DNA Atlas: revealing fine-scale population structure and history within Ireland","volume":"7","author":"Gilbert","year":"2017","journal-title":"Sci Rep"},{"key":"10.1111\/jcpt.12768-BIB0056|jcpt12768-cit-0056","doi-asserted-by":"crossref","first-page":"171024","DOI":"10.1098\/rsos.171024","article-title":"Network analysis of the Viking age in Ireland as portrayed in Cogadh Gaedhelre Gallaibh","volume":"5","author":"Yose","year":"2018","journal-title":"R Soc Open Sci"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12768","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12768\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:03:54Z","timestamp":1671800634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12768","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,11]]}}}